Advertisement

Archives of Dermatological Research

, Volume 310, Issue 7, pp 537–549 | Cite as

Stratum corneum substantivity: drug development implications

  • Becky S. Li
  • John Havens Cary
  • Howard I. Maibach
Review

Abstract

There are at least 15 factors that influence the ability of chemicals to penetrate the skin. Substantivity is yet another factor and allows penetrants to remain on and in skin for many days. As many skin pathologies involve stratum corneum and require multiple dosing of topicals, understanding substantivity mechanisms may provide insight for topical dosing strategies. Substantivity is also of importance in the development of other consumer products that necessitate adherence to skin, including sunscreens, insect repellents, and cosmetics. Furthermore, while stratum corneum adherence may delay percutaneous penetration, reducing the risk of systemic toxicity, excessive substantivity may play a role in the toxic accumulation of harmful penetrants. Continued research in this area may offer insight into dermatotoxicology and dermatopharmacology.

Keywords

Substantivity Stratum corneum adherence Stratum corneum binding Percutaneous penetration 

Notes

Funding

No funding was received for this article.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

This article does not contain any studies with human participants or animals performed by any of the authors; therefore, informed consent is not applicable.

References

  1. 1.
    Aalto-Korte K (1995) Improvement of skin barrier function during treatment of atopic dermatitis. J Am Acad Dermatol 33:969–972CrossRefPubMedGoogle Scholar
  2. 2.
    Aly R, Maibach HI (1979) Comparative study on the antimicrobial effect of 0.5% chlorhexidine gluconate and 70% isopropyl alcohol on the normal flora of hands. Appl Environ Microbiol 37(3):610–613PubMedPubMedCentralGoogle Scholar
  3. 3.
    Arancibia A, Borie G, Cornwell E, Medrano C (1981) Pharmacokinetic study on the percutaneous absorption of p-aminobenzoic acid from three sunscreen preparations. Farmaco Prat 36(8):357–365PubMedGoogle Scholar
  4. 4.
    Baldwin JN, Rheins MS, Sylvester RF Jr, Shaffer TE (1957) Staphylococcal infections in newborn infants. AMA J Dis Child 94(2):107–116CrossRefPubMedGoogle Scholar
  5. 5.
    Benech-Kieffer F, Wegrich P, Schwarzenbach R, Klecak G, Weber T, Leclaire J, Schaefer H (2000) Percutaneous absorption of sunscreens in vitro: interspecies comparison, skin models and reproducibility aspects. Skin Pharmacol Appl Skin Physiol 13(6):324–335.  https://doi.org/10.1159/000029940 CrossRefPubMedGoogle Scholar
  6. 6.
    Biebl KA, Warshaw EM (2006) Allergic contact dermatitis to cosmetics. Dermatol Clin 24(2):215–232.  https://doi.org/10.1016/j.det.2006.01.006 CrossRefPubMedGoogle Scholar
  7. 7.
    Bollinger JN, Seelig LL (1970) Adherence of vegetable bath oils to keratin. J Soc Cosmet Chem 21(9):613–623Google Scholar
  8. 8.
    Boosalis M, McCall J, Ahrenholz D, Solem L, McClain C (1987) Serum and urinary silver levels in thermal injury patients. Surgery 101:40–43PubMedGoogle Scholar
  9. 9.
    Bottari F, Nannipieri E, Saettone MF, Serafini MF (1978) Substantivity of sunscreens: a study on the interaction of four alkyl 4-aminobenzoates with keratin. J Soc Cosmet Chem 29:353–363Google Scholar
  10. 10.
    Brieva H, Russ JG, Sandewicz IM (2004) Cosmetic compositions. US Patent 6:780,422Google Scholar
  11. 11.
    Cao Y, Elmahdy A, Zhu H, Hui X, Maibach H (2018) Binding affinity and decontamination of dermal decontamination gel to model chemical warfare agent simulants. J Appl Toxicol.  https://doi.org/10.1002/jat.3580 CrossRefPubMedGoogle Scholar
  12. 12.
    Carroll FE Jr, Salak WW, Howard JM, Pairent FW (1967) Absorption of antimicrobial agents across experimental wounds. Surg Gynecol Obstet 125(5):974–978PubMedGoogle Scholar
  13. 13.
    Chilcote R, Curley A, Loughlin HH, Jupin JA (1977) Hexachlorophene storage in a burn patient associated with encephalopathy. Pediatrics 59(3):457–459PubMedGoogle Scholar
  14. 14.
    Cumpelik B (1976) Substantivity of sunscreens. Cosmet Toilet 91:59–62Google Scholar
  15. 15.
    de Gennes PG (2001) Ultradivided matter. Nature 412(6845):385.  https://doi.org/10.1038/35086662 CrossRefPubMedGoogle Scholar
  16. 16.
    Drechsler LE, Rabe TE, Smith ED (2000) Transfer resistant cosmetic compositions. US Patent 6:071,503Google Scholar
  17. 17.
    Farquharson CD, Penny SF, Edwards HE, Barr E (1952) The control of staphylococcal skin infections in the nursery. Can Med Assoc J 67(3):247–249PubMedPubMedCentralGoogle Scholar
  18. 18.
    Feldmann RJ, Maibach HI (1965) Penetration of 14C hydrocortisone through normal skin: the effect of stripping and occlusion. Arch Dermatol 91:661–666CrossRefPubMedGoogle Scholar
  19. 19.
    Feldmann RJ, Maibach HI (1970) Absorption of some organic compounds through the skin in man. J Investig Dermatol 54(5):399–404.  https://doi.org/10.1111/1523-1747.ep12259184 CrossRefPubMedGoogle Scholar
  20. 20.
    Flynn GL, Behl CR, Walters KA, Gatmaitan OG, Wittkowsky A, Kurihara T, Ho NF, Higuchi WI, Pierson CL (1980) Permeability of thermally damaged skin III: influence of scalding temperature on mass transfer of water and n-alkanols across hairless mouse skin. Burns 8:47–58CrossRefGoogle Scholar
  21. 21.
    Gattu S, Maibach HI (2010) Enhanced absorption through damaged skin: an overview of the in vitro human model. Skin Pharmacol Physiol 23(4):171–176CrossRefPubMedGoogle Scholar
  22. 22.
    Gattu S, Maibach HI (2011) Modest but increased penetration through damaged skin: an overview of the in vivo human model. Skin Pharmacol Physiol 24(1):2–9.  https://doi.org/10.1159/000314995 CrossRefPubMedGoogle Scholar
  23. 23.
    Gluck L, Wood HF (1961) Effect of an antiseptic skin-care regimen in reducing in reducing staphylococcal colonization in newborn infants. N Engl J Med 265(24):1177–1181.  https://doi.org/10.1056/NEJM196112142652402 CrossRefPubMedGoogle Scholar
  24. 24.
    Goddard E, Faucher J, Scott R, Turney M (1975) Adsorption of polymer JR on keratinous surfaces—Part II. J Soc Cosmet Chem 26:539–550Google Scholar
  25. 25.
    Gonzalez H, Farbrot A, Larko O, Wennberg AM (2006) Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br J Dermatol 154(2):337–340.  https://doi.org/10.1111/j.1365-2133.2005.07007.x CrossRefPubMedGoogle Scholar
  26. 26.
    Goossens A, Beck MH, Haneke E, McFadden JP, Nolting S, Durupt G, Ries G (1999) Adverse cutaneous reactions to cosmetic allergens. Contact Dermat 40(2):112–113CrossRefGoogle Scholar
  27. 27.
    Goutieres F, Aicardi J (1977) Accidental percutaneous hexachlorophane intoxication in children. Br Med J 2(6088):663–665.  https://doi.org/10.1136/bmj.2.6088.663 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Gump WS (1945) The development of a germicidal soap. Soap Sanit Chem 21:36–50Google Scholar
  29. 29.
    Gump WS (1969) Toxicological properties of hexachlorophene. J Soc Cosmet Chem 20(3):173–184Google Scholar
  30. 30.
    Gupta VK, Zatz JL, Rerek M (1999) Percutaneous absorption of sunscreens through micro-Yucatan pig skin in vitro. Pharm Res 16(10):1602–1607.  https://doi.org/10.1023/A:1018916907263 CrossRefPubMedGoogle Scholar
  31. 31.
    Havens I, Benham RS, Clark DE (1957) Hexachlorophene in the surgical scrub. Am J Med Technol 23(2):76–86PubMedGoogle Scholar
  32. 32.
    Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, Mark R, Naldi L, Weinstock MA, Wulf SK, Michaud C, Murray CJL, Naghavi M (2014) The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Investig Dermatol 134:1527–1534CrossRefPubMedGoogle Scholar
  33. 33.
    Hayden CG, Roberts MS, Benson HA (1997) Systemic absorption of sunscreen after topical application. Lancet 350(9081):863–864.  https://doi.org/10.1016/S0140-6736(05)62032-6 CrossRefPubMedGoogle Scholar
  34. 34.
    Heneweer M, Muusse M, van den Berg M, Sanderson JT (2005) Additive estrogenic effects of mixtures of frequently used UV filters on pS2-gene transcription in MCF-7 cells. Toxicol Appl Pharmacol 208:170–177CrossRefPubMedGoogle Scholar
  35. 35.
    Herter WB (1959) Hexachlorophene poisoning. Kaiser Found Med Bull 7:228Google Scholar
  36. 36.
    Jakasa I, Verberk M, Bunge A, Kruse J, Kezić S (2006) Increased permeability for polyethylene glycols through skin compromised by sodium lauryl sulphate. Exp Dermatol 15:801–807CrossRefPubMedGoogle Scholar
  37. 37.
    Kienzler JL, Queille-Roussel C, Mugglestone C, Ortonne JP, Larnier C (2007) Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses. Curr Med Res Opin 23(6):1293–1302.  https://doi.org/10.1185/030079907X199664 CrossRefPubMedGoogle Scholar
  38. 38.
    Kimbrough RD (1971) Review of the toxicity of hexachlorophene. Arch Environ Health 23(2):119–122.  https://doi.org/10.1080/00039896.1971.10665967 CrossRefPubMedGoogle Scholar
  39. 39.
    Klammer H, Schlecht C, Wuttke W, Jarry H (2005) Multi-organic risk assessment of estrogenic properties of octyl-methoxycinnamate in vivo. A 5-day sub-acute pharmacodynamic study with ovariectomized rats. Toxicology 215:90–96CrossRefPubMedGoogle Scholar
  40. 40.
    Koch FC, Hanke ME (1948) Practical methods in biochemistry, 5th edn. Williams And Wilkins Company, BaltimoreGoogle Scholar
  41. 41.
    Krzysik DG (1994) Cosmetics with enhanced durability. US Patent 5:330,747Google Scholar
  42. 42.
    Kunz PY, Fent K (2006) Estrogenic activity of UV filter mixtures. Toxicol Appl Pharmacol 217:86–99CrossRefPubMedGoogle Scholar
  43. 43.
    Larose P, Fischer R (1952) A test for bactericidal activity in which bacteria are replaced by wool. Research (London) 5:419–423Google Scholar
  44. 44.
    Larson DL (1968) Studies show hexachlorophene causes burn syndrome. Hospitals 42(24):63–64PubMedGoogle Scholar
  45. 45.
    Larson DL, Abston S, Bachmann RC (1971) Hexachlorophene absorption from the burn wound. In: Matter P, Barclay TL, Konickova Z (eds) Research in burns. Hans Huber, Vienna, p 619Google Scholar
  46. 46.
    Lewis DJ, Feldman SR (2017) Practical ways to improve patient adherence. CreateSpace Independent Publishing Platform, MiddletownGoogle Scholar
  47. 47.
    Leyden JJ, Stewart R, Kligman AM (1979) Updated in vivo methods for evaluating topical antimicrobial agents on human skin. J Investig Dermatol 72(4):165–170.  https://doi.org/10.1111/1523-1747.ep12676347 CrossRefPubMedGoogle Scholar
  48. 48.
    Lockhart SP, Rushworth A, Azmy AA, Raine PA (1983) Topical silver sulphadiazine: side effects and urinary excretion. Burns Incl Therm Inj 10:9–12CrossRefPubMedGoogle Scholar
  49. 49.
    Lunter DJ, Rottke M, Daniels R (2014) Oil-in-oil-emulsions with enhanced substantivity for the treatment of chronic skin diseases. J Pharm Sci 103(5):1515–1519.  https://doi.org/10.1002/jps.23944 CrossRefPubMedGoogle Scholar
  50. 50.
    Maibach HI, Kligman AM (1960) Dihydroxyacetone: a suntan-simulating agent. Arch Dermatol 82(4):505–507.  https://doi.org/10.1001/archderm.1960.01580040023004 CrossRefPubMedGoogle Scholar
  51. 51.
    Manowitz M, Johnston VD (1967) Deposition of hexachlorophene on the skin. J Soc Cosmet Chem 18(8):527–536Google Scholar
  52. 52.
    Marples RR, Kligman AM (1974) Methods for evaluating topical antibacterial agents on human skin. Antimicrob Agents Chemother 5(3):323–329CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Martin-Bouyer G, Lebreton R, Toga M, Stolley PD, Lockhart J (1982) Outbreak of accidental hexachlorophene poisoning in France. Lancet 1(8263):91–95.  https://doi.org/10.1016/S0140-6736(82)90225-2 CrossRefPubMedGoogle Scholar
  54. 54.
    McNamara TF, Steinbach M (1967) In vitro evaluation of the tissue substantivity of selected antibacterial agents. J Am Oil Chem Soc 44(8):478–480.  https://doi.org/10.1007/bf02908539 CrossRefPubMedGoogle Scholar
  55. 55.
    Menczel E, Maibach HI (1970) In vitro human percutaneous penetration of benzyl alcohol and testosterone: epidermal–dermal retention. J Investig Dermatol 54(5):386–394CrossRefPubMedGoogle Scholar
  56. 56.
    Menkart J (1979) An analysis of adverse reactions to cosmetics. Cutis 24(6):599–662PubMedGoogle Scholar
  57. 57.
    Merchant S, Pathak V (1977) The role of barrier creams in cases of industrial dermatitis. Indian J Occup Health 20:45–47Google Scholar
  58. 58.
    Mertz PM, Alvarez OM, Smerbeck RV, Eaglstein WH (1984) A new in vivo model for the evaluation of topical antiseptics on superficial wounds. The effect of 70% alcohol and povidone-iodine solution. Arch Dermatol 120(1):58–62.  https://doi.org/10.1001/archderm.1984.01650370064012 CrossRefPubMedGoogle Scholar
  59. 59.
    Monti D, Saettone MF, Centini M, Anselmi C (1993) Substantivity of sunscreens in vitro evaluation of the transdermal permeation characteristics of some benzophenone derivatives. Int J Cosmet Sci 15(2):45–52.  https://doi.org/10.1111/j.1467-2494.1993.tb00068.x CrossRefPubMedGoogle Scholar
  60. 60.
    Morasso MI, Thielemann AM, Pinto C, Figueroa M, Arancibia A (1985) In vitro and in vivo study of the substantivity of p-amino benzoic acid and two of its esters. J Soc Cosmet Chem 36:355–362Google Scholar
  61. 61.
    Morgan C, Renwick A, Friedmann P (2003) The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol 148:434–443CrossRefPubMedGoogle Scholar
  62. 62.
    Morohoshi K, Yamamoto H, Kamata R, Shiraishi F, Koda T, Morita M (2005) Estrogenic activity of 37 components of commercial sunscreen lotions evaluated by in vitro assays. Toxicol In Vitro 19:457–469CrossRefPubMedGoogle Scholar
  63. 63.
    Murakami T, Yoshioka M, Okamoto I, Yumoto R, Higashi Y, Okahara K, Yata N (1998) Effect of ointment bases on topical and transdermal delivery of salicylic acid in rats: evaluation by skin microdialysis. J Pharm Pharmacol 50:55–61CrossRefPubMedGoogle Scholar
  64. 64.
    Ngo MA, Maibach HI (2012) 15 Factors of percutaneous penetration of pesticides. In: Knaak JB, Timchalk C, Tornero-Velez R (eds) Parameters for pesticide QSAR and PBPK/PD models for human risk assessment. Oxford University Press, Danvers, pp 67–86CrossRefGoogle Scholar
  65. 65.
    Reid DE, Walter CW, Buck AS (1950) Surgical scrubbing with pHisoderm G-11 as applied to a maternity hospital. Surg Gynecol Obstet 91(5):537–544PubMedGoogle Scholar
  66. 66.
    Ricci C, Pazzaglia M, Tosti A (1998) Photocontact dermatitis from UV filters. Contact Dermat 38(6):343–344.  https://doi.org/10.1111/j.1600-0536.1998.tb05777.x CrossRefGoogle Scholar
  67. 67.
    Saettone MF, Giannaccini B, Morganti C, Persi A, Cipriani C (1986) Substantivity of sunscreens: an appraisal of some quaternary ammonium sunscreens. Int J Cosmet Sci 8(1):9–25.  https://doi.org/10.1111/j.1467-2494.1986.tb00426.x CrossRefPubMedGoogle Scholar
  68. 68.
    Scheuplein RJ (1969) Mechanism of percutaneous adsorption. J Investig Dermatol 45:334CrossRefGoogle Scholar
  69. 69.
    Schlumpf M, Cotton B, Conscience M, Haller V, Steinmann B, Lichtensteiger W (2001) In vitro and in vivo estrogenicity of UV screens. Environ Health Perspect 109:239–244CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Schlumpf M, Schmid P, Durrer S, Conscience M, Maerkel K, Henseler M, Gruetter M, Herzog I, Reolon S, Ceccatelli R, Faass O, Stutz E, Jarry H, Wuttke W, Lichtensteiger W (2004) Endocrine activity and developmental toxicity of cosmetic UV filters—an update. Toxicology 205(1–2):113–122.  https://doi.org/10.1016/j.tox.2004.06.043 CrossRefPubMedGoogle Scholar
  71. 71.
    Seidlova-Wuttke D, Christoffel J, Rimoldi G, Jarry H, Wuttke W (2006) Comparison of effects of estradiol with those of octylmethoxycinnamate and 4-methylbenzylidene camphor on fat tissue, lipids and pituitary hormones. Toxicol Appl Pharmacol 214:1–7CrossRefPubMedGoogle Scholar
  72. 72.
    Seidlova-Wuttke D, Jarry H, Christoffel J, Rimoldi G, Wuttke W (2006) Comparison of effects of estradiol (E2) with those of octylmethoxycinnamate (OMC) and 4-methylbenzylidene camphor (4MBC)-2 filters of UV light—on several uterine, vaginal and bone parameters. Toxicol Appl Pharmacol 210:246–254CrossRefPubMedGoogle Scholar
  73. 73.
    Shemano I, Nickerson M (1954) Cutaneous accumulation and retention of hexachlorophene-C14 (G-11). Fed Proc 13:404Google Scholar
  74. 74.
    Touitou E, Godin B (2006) New approaches for UV-induced photodamage protection. J Appl Cosmetol 24:139–147Google Scholar
  75. 75.
    Walling DW, Wujek SM, Levine F, Coleman-Nally DJ (1999) Transfer-resistant lip compositions. US 5,948,394Google Scholar
  76. 76.
    Ward WH, Lundgren HP (1954) The formation, composition, and properties of the keratins. Adv Protein Chem 9:243–297CrossRefPubMedGoogle Scholar
  77. 77.
    Warshaw EM, Buchholz HJ, Belsito DV, Maibach HI, Fowler JF Jr, Rietschel RL, Zug KA, Mathias CG, Pratt MD, Sasseville D, Storrs FJ, Taylor JS, Deleo VA, Marks JG Jr (2009) Allergic patch test reactions associated with cosmetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001–2004. J Am Acad Dermatol 60(1):23–38.  https://doi.org/10.1016/j.jaad.2008.07.056 CrossRefPubMedGoogle Scholar
  78. 78.
    Wester RC, Maibach HI (1983) Cutaneous pharmacokinetics: 10 steps to percutaneous absorption. Drug Metab Rev 14(2):169–205CrossRefPubMedGoogle Scholar
  79. 79.
    Wester RC, Melendres J, Sedik L, Maibach H, Riviere JE (1998) Percutaneous absorption of salicylic acid, theophylline, 2, 4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo. Toxicol Appl Pharmacol 151(1):159–165.  https://doi.org/10.1006/taap.1998.8434 CrossRefPubMedGoogle Scholar
  80. 80.
    Williams REO, Blowers R, Garrod LP, Shooter RA (1966) Hospital infections. Causes and prevention. Lloyd-Luke, LondonGoogle Scholar
  81. 81.
    Wurster DE, Dempski RE (1960) Adsorption of lipid-soluble substances by human keratin. J Am Pharm Assoc Am Pharm Assoc 49(5):305–307.  https://doi.org/10.1002/jps.3030490513 CrossRefPubMedGoogle Scholar
  82. 82.
    Zhai H, Maibach HI (1996) Effect of barrier creams: human skin in vivo. Contact Dermat 35(2):92–96.  https://doi.org/10.1111/j.1600-0536.1996.tb02297.x CrossRefGoogle Scholar

Related articles recently published in Archives of Dermatological Research (selected by the journal’s editorial staff)

  1. 83.
    Alonso C, Marti M, Barba C, Carrer V, Rubio L, Coderch L (2017) Skin permeation and antioxidant efficacy of topically applied resveratrol. Arch Dermatol Res 309:423–431CrossRefPubMedGoogle Scholar
  2. 84.
    Evans RL, Turner GA, Bates S, Robinson T, Arnold D, Marriott RE, Pudney PDA, Bonnist EYM, Green D (2017) Human axillary skin condition is improved following incorporation of glycerol into the stratum corneum from an antiperspirant formulation. Arch Dermatol Res 309:739–748CrossRefPubMedGoogle Scholar
  3. 85.
    Li WH, Wong HK, Serrano J, Randhawa M, Kaur S, Southall MD, Parsa R (2017) Topical stabilized retinol treatment induces the expression of HAS genes and HA production in human skin in vitro and in vivo. Arch Dermatol Res 309:275–283CrossRefPubMedGoogle Scholar
  4. 86.
    Sidgwick GP, McGeorge D, Bayat A (2016) Functional testing of topical skin formulations using an optimised ex vivo skin organ culture model. Arch Dermatol Res 308:297–308CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Howard University College of MedicineWashingtonUSA
  2. 2.Louisiana State University School of MedicineNew OrleansUSA
  3. 3.Department of Dermatology, School of MedicineUniversity of California, San FranciscoSan FranciscoUSA

Personalised recommendations